Video

Concerns Over Drug Interaction Alert Fatigue

Daniel C. Malone, RPh, PhD, FAMCP, defines drug interaction alert fatigue.

Daniel C. Malone, RPh, PhD, FAMCP, a professor of pharmacy at the University of Arizona College of Pharmacy, defines drug interaction alert fatigue.

This interview was recorded at the ASHP 2014 Midyear Clinical Meeting in Anaheim, California.

Newsletter

Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.

Subscribe Now!
Related Videos
Psychiatric pharmacist and patient -- Image credit: NanSan | stock.adobe.com
Psychiatric pharmacist -- Image credit: HBS | stock.adobe.com
Hematology -- Image credit: DIgilife | stock.adobe.com
Related Content
Independent Pharmacy Owners Harness Grassroots Strategies and Technology to Build Stronger Communities
July 14th 2025

Independent Pharmacy Owners Harness Grassroots Strategies and Technology to Build Stronger Communities

Aislinn Antrim, Managing Editor
Pharmacy Focus: Importance of Mental Health for Patients and Pharmacists Alike
July 10th 2025

Pharmacy Focus: Importance of Mental Health for Patients and Pharmacists Alike

Gustavo Alva, MD Luke Halpern, Assistant Editor
Online pharmacy. Lots of pills, stethoscope and boxes with medication. The concept of convenient choice of medicines.
July 14th 2025

Is There a Marketplace for Mail Order?

Troy Trygstad, PharmD, PhD, MBA, Pharmacy Times Editor in Chief
Pharmacy Focus: Navigating Seasonal Allergies
May 28th 2025

Pharmacy Focus: Navigating Seasonal Allergies

Luke Halpern, Assistant Editor Derek Webb, PharmD
Elderly woman applying moisturizing lotion cream on hand palm, easing aches. Senior old lady experiencing severe arthritis rheumatics pains, massaging, warming up arm.
July 14th 2025

Pneumococcal Vaccination Linked With Reduced COVID-19 Hospitalization, Death in Inflammatory Rheumatic Diseases

Luke Halpern, Assistant Editor
Stethoscope, red heart and cardiogram on gray table. Cardiology concept
July 14th 2025

Finerenone Approved by FDA for Treatment of Adults With Heart Failure

Luke Halpern, Assistant Editor